Logo

Vol. 117, Suppl. 1

November 30, 2007
On this page
Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development
Katarzyna Fischer, Marek Brzosko, Anna Walecka, Lidia Ostanek, Marcin Sawicki
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 256; DOI: 10.20452/pamw.256
Ocular manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome
Lidia Ostanek, Monika Modrzejewska, Danuta Bobrowska-Snarska, Marek Brzosko
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 18–23; DOI: 10.20452/pamw.258
Anticardiolipin and anti-β2 glycoprotein-I antibodies patients with breast carcinoma: a pilot study
Irena Zimmermann-Górska, Sylwia Grodecka-Gazdecka, Grażyna Białkowska-Puszczewicz, Mariusz Puszczewicz, Magdalena Goździecka, Paweł Kondarewicz
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 24–27; DOI: 10.20452/pamw.260
20th anniversary of the antiphospholipid syndrome
Irena Zimmermann-Górska
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 8–12; DOI: 10.20452/pamw.254
Multiple sclerosis and antiphospholipid syndrome – difficulties in differential diagnostics
Anna Członkowska, Anna Śliwińska
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 28–32; DOI: 10.20452/pamw.262
The prevalence and clinical significance of antiphoshpolipid antibodies in rheumatoid arthritis
Anna Filipowicz-Sosnowska, Robert Rupiński, Ewa Walewska
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 33–38; DOI: 10.20452/pamw.264
Pulmonary embolism in the course of antiphospholipid syndrome
Wojciech Dyszkiewicz, Łukasz Gąsiorowski
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 39–40; DOI: 10.20452/pamw.266
The management of pregnant women with antiphospholipid syndrome
Jana Skrzypczak
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 50–54; DOI: 10.20452/pamw.272
Antiphospholipid antibodies – risk factors for venous thromboembolism and arterial thrombosis
Krystyna Zawilska
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 41–45; DOI: 10.20452/pamw.268
Cechy ultrastrukturalne prawidłowego i dysfunkcyjnego śródbłonka naczyń krwionośnych Michał Walski, Małgorzata Frontczak-Baniewicz
Michał Walski, Małgorzata Frontczak-Baniewicz
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 46–49; DOI: 10.20452/pamw.270
The kidneys and antiphospholipid syndrome
Maria Majdan
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 55–58; DOI: 10.20452/pamw.274
β2 glycoprotein-I – the main antigen in antiphospholipid syndrome
Jacek Musiał
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 59–60; DOI: 10.20452/pamw.276
Infections and antiphospholipid syndrome
Jakub Ząbek
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 61–64; DOI: 10.20452/pamw.278
Therapy resistance antiphosholipid syndrome in the course of systemic lupus erythematosus: case report
Danuta Bobrowska-Snarska, Lidia Ostanek, Beata Trzcińska-Butkiewicz, Marek Brzosko
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 65–69; DOI: 10.20452/pamw.280
Amaurosis fugax?
Joanna Kur-Zalewska, Mateusz Tłustochowicz, Witold Tłustochowicz
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 70–72; DOI: 10.20452/pamw.282
Orthopedic complications of antiphospholipid syndrome: presentation of two cases
Mariusz Piotrowski, Maria Majdan, Mirosław Jabłoński, Mieczysław Gorzelak
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 73–75; DOI: 10.20452/pamw.284
The overlap of primary Sjögren’s syndrome with antiphospholipid syndrome in man: case report
Ewa Wielosz, Maria Majdan, Arkadiusz Koszarny, Iwona Żychowska
Pol Arch Intern Med. 2007, Vol. 117, Suppl. 1: 76–78; DOI: 10.20452/pamw.286